Need to Know
Business and Stock Market News
Need To Know highlights news from across the industry, and from a variety of sources. Click on a headline to read more…
- Global recommendations on child medicine
- Breakup of physician, drug company relationship could improve health care, cut cost
- Nanotechnology could help fight diabetes
- AstraZeneca issues update on accelerated oncology pipeline
- First prospective trial shows molecular profiling timely for tailoring therapy
- GSK and Save the Children form unique partnership to save the lives of one million children
- Breakthrough in how pancreatic cancer cells ingest nutrients points to new drug target
- Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis
- Amgen and Zhejiang Beta Pharma announce planned joint venture in China
- Boehringer Ingelheim joins Structural Genomics Consortium
- Real-world data at ARVO highlight transformational outcomes seen with Lucentis®
- New class of drug targets skin cancer
- Bristol-Myers Squibb and Pfizer announce publication of ARISTOTLE subanalysis in Circulation
- Funding boost for GSK's open innovation research into diseases affecting the developing world
- Study opens new prospects for developing new targeted therapies for breast cancer
- Experts discuss ways to embed patient voices and values in clinical research
- Lundbeck is well on track to deliver on guidance for 2013
- Cancer studies often lack necessary rigor to answer key questions
- Bayer: Life Sciences off to a good start in anniversary year
- Bristol-Myers Squibb reports first quarter 2013 financial results
